Corpay Cross-Border declares new Triterras collaboration

 KUALA LUMPUR, June 29 (Bernama) -- Corpay, a FLEETCOR® brand and global leader in business payments, and Triterras Inc, a global fintech company and leading innovator of inclusive finance solutions for the world’s micro, small and medium enterprises (MSME’s) have announced a new collaboration between Corpay’sCross-Border business and Triterras Inc.

Through this collaboration, both Triterras and its Kratos platform members can gain access to and utilise Corpay’s innovative solutions to help mitigate foreign exchange exposure for their day-to-day business needs.

Additionally, Corpay Cross-Border’s award-winning platform will enable both Triterras and Kratos members to manage their global payments from a single point of access.

Clients who choose Corpay for their global payments and foreign currency exchange transactions will undergo Corpay Cross-Borders’s onboarding process, which includes but is not limited to due diligence checks and know your client (KYC) procedures.

“We’re very excited to onboard Triterras as a new customer, as well as our new partner. I am confident that both Triterras and Kratos platform members looking to better streamline their payments processes and effectively manage their FX exposure will benefit from access to our comprehensive cross-border payments and currency risk management solutions,” says David Britten, Managing Director APAC, Corpay Cross-Border in a statement.

“Our team in APAC looks forward to helping these enterprises power their cross-border payments, execute plans to manage their currency risk and support their aspirations to grow their businesses globally.”

“We’re always looking for ways to fortify our Kratos platform to potentially save our clients time and money. Corpay offers Kratos members—as well as Triterras—world-class payments and foreign exchange hedging solutions that give MSMEs a competitive edge and keep their businesses safe.

“We’re extremely glad to have a relationship and collaborate with Corpay to help make MSMEs run smarter across their daily trading operations,” said SrinivasKoneru, Founder and CEO of Triterras.

For more information, visit https://payments.corpay.com/cross-border;

-- BERNAMA

India's pioneering group-buying social commerce platform Gobillion witnesses outlier growth

KUALA LUMPUR, June 30 (Bernama) -- Since the pandemic, the e-commerce industry in India has grown massively riding on increased adoption by customers, with 80 per cent smartphone users coming from small towns.

However, the legacy e-commerce model is built to serve the needs of India's premium customers from large cities, excluding the intrinsic needs of customers from small towns in India, which account for roughly 90 per cent of India’s population.

Gobillion, launched with the mission of making e-commerce social and accessible for the next 500 million customers in tier 2+ towns in India, enables customers to socially group buy together with other customers and unlock massive discounts on their grocery and daily essentials.

According to a statement, Gobillion co-founders, Roshan Farhan and Kulapradip Bharali, are IIM-NIT alumni and close friends.

The company has witnessed outlier growth in its operating markets with 10.4x growth in GMV over the last eight months, currently at a US$12 million annualised GMV run-rate, with industry leading customer retention metrics. They are backed by YCombinator and top tier global VC funds. (US$1 = RM4.402)

In India’s small towns, dynamics are very different - people live in close-knit communities, their shopping decisions are influenced by family and friends. Gobillion augments this real life behaviour and brings the social experience to an app through their global first product, Gobillion Shopping Rooms.

Gobillion plans to expand across India and SE Asia, bringing the benefits of e-commerce to everybody. They are targeting a US$100 billion market ripe for disruption.

With its outlier growth, the company is planning to raise their Series A investment round to maintain their growth and launch in new markets.

With the industry leading growth they are witnessing and the first movers advantage, Gobillion is looking at becoming the market leader in the social commerce market in India and SE Asia.

-- BERNAMA

Adagene declares share repurchase programme authorisation up to US$10 million

KUALA LUMPUR, June 30 (Bernama) -- Adagene Inc (Adagene) a company transforming the discovery and development of novel antibody-based therapies, announced that its board of directors has authorised a share repurchase programme.

Under the programme, Adagene may repurchase up to US$10 million of its ordinary shares in the form of American depositary shares, subject to the relevant rules under the Securities Exchange Act of 1934, as amended (the Exchange Act), and the Company’s insider trading policy (such repurchase programme, the 2022 Share Repurchase Program). (US$1 = RM4.402)

The Company’s share repurchases, if any, under the 2022 Share Repurchase Program may be made from time to time on the open market at prevailing market prices, in open-market transactions, privately negotiated transactions or block trades, and/or through other legally permissible means, depending on market conditions and in accordance with the applicable rules and regulations.

The Company’s board of directors will review the 2022 Share Repurchase Program periodically and may authorise adjustments to its terms and size or suspend or discontinue the programme. The Company expects to utilise its existing funds to fund repurchases made under this programme.

According to a statement, the Company has disclosed certain details of the repurchases made in accordance with the prior share repurchase programme in its annual report for the year ended Dec 31, 2021 filed with the SEC.

The 2022 Share Repurchase Program will be effective upon and from the date on which a formal stock repurchase plan engagement agreement is signed with a qualified broker-dealer(s), and terminates over a 12-month period depending upon market and economic conditions, and other factors including price, legal and regulatory requirements and capital availability.

The 2022 Share Repurchase Program does not obligate Adagene to acquire any particular number of American depositary shares, and the 2022 Share Repurchase Program may be modified or suspended at any time based on the management's discretion.

More details at https://investor.adagene.com.

-- BERNAMA

CITELINE AND NORSTELLA UNITE TO OFFER LIFE SCIENCES CLIENTS A FULL SUITE OF COMMERCIAL AND CLINICAL SOLUTIONS

The new organization will help life sciences companies improve strategic decision-making and accelerate the mission of smoothing access to therapy from pipeline to patient


Yardley, PA, June 29 (Bernama-GLOBE NEWSWIRE) -- Norstella, an organization that helps life sciences companies navigate the complexities of the drug life cycle, and Citeline (formerly Pharma Intelligence)—a leading provider of specialist intelligence, data and software for clinical trials, drug development and regulatory compliance—have announced an agreement to merge the companies.

By uniting Norstella, which is comprised of four prominent pharmaceutical solutions providers—Evaluate, MMIT, Panalgo and The Dedham Group—with Citeline, the combined company will be well positioned to help life sciences companies reach patients faster by providing clients with the intelligence and answers they need from early clinical development through to commercialization. This move reflects the shared goal of becoming an end-to-end solution provider, helping patients access life-saving therapies.

As life sciences companies drive innovation toward more specialized therapeutics across all disease areas including oncology and rare disease, and patient populations become more targeted, they need to make critical decisions about how to bring the right drugs to market, how to construct clinical trials leveraging the latest innovations in real-world data and data science—and with end points that consider future payer reimbursement decisions—and, ultimately, how to reach patients in need.

“Accelerating innovation and ensuring that every patient gets the therapy that they need is our North Star,” said Norstella CEO Mike Gallup. “By bringing clinical and commercial intelligence together—along with real-world data—the combined company will be well positioned to deliver on its mission.”

Together, Norstella and Citeline will play a critical role in helping pharmaceutical manufacturers plan for and overcome barriers to access, not just during clinical trials but at every stage in the drug development life cycle. Citeline’s solutions, including its portfolio of clinical trial products, provide insights that improve the speed and efficiency of clinical trials and reduce risk. Now, the Citeline solutions—along with MMIT’s PAR data and other complementary Norstella data assets—can be powered by Panalgo’s Instant Health Data Analytics platform to provide transformative answers that will improve workflow and decision-making and, ultimately, help products get to market and to patients quicker than ever before.

“At Citeline, our mission is to accelerate the connection of treatments to patients and patients to treatments. Ultimately, this marriage of commercial and clinical capabilities will advance the mission and enable the pharmaceutical C-suite to manage portfolio strategy like never before,” said Ramsey Hashem, CEO, and Jay Nadler, Executive Chair, of Citeline. “This includes deciding which drug to bring to market, what new indications to pursue for a drug and how to target patients for clinical trials more quickly and with reduced cost. And now, this includes understanding how to design clinical trials that yield the types of data that payers need to make appropriate reimbursement and formulary decisions.”

“It’s about making a difference in the lives of patients,” said Gallup. “This move will help us make our vision of a more innovative, accessible healthcare marketplace a reality.”

The merger is expected to close in the second half of 2022 subject to customary closing conditions and regulatory approvals. 

###

About Norstella
At Norstella, our mission is simple: to help patients gain access to life-saving therapies. Norstella consists of several prominent organizations—Evaluate, MMIT, Panalgo and The Dedham Group—that have united to offer a full range of pharmaceutical consultancy services and solutions. As one organization, Norstella provides life sciences clients with the right tools and expertise to navigate complexities at each step of the drug development life cycle, from pipeline to patient. For more information, visit Norstella and follow on LinkedIn.

About Citeline
Citeline (formerly Pharma Intelligence) powers a full suite of complementary business intelligence offerings to meet the evolving needs of health science professionals to accelerate the connection of treatments to patients and patients to treatments. These patient-focused solutions and services deliver and analyze data used to drive clinical, commercial, and regulatory related-decisions and create real-world opportunities for growth. 

Our global teams of analysts, journalists and consultants keep their fingers on the pulse of the pharmaceutical, biomedical and medtech industries, covering it all with expert insights: key diseases, clinical trials, drug R&D and approvals, market forecasts and more. For more information on one of the world’s most trusted health science partners, visit Citeline.

Melody Udell
Norstella
312-618-5968
melody.udell@norstella.com

Blair Dawson
Citeline
919-413-4616
blair.dawson@informa.com

SOURCE : Norstella

US FDA APPROVES PRESTIGE BIOPHARMA'S IND FOR PHASE 1/2A TRIAL OF FIRST-IN-CLASS PANCREATIC CANCER TREATMENT, PBP1510

SINGAPORE, June 27 (Bernama-BUSINESS WIRE) -- Prestige Biopharma Limited, a Singapore-based biopharmaceutical company with operations in USA and South Korea, announced that the U.S. Food and Drug Administration (FDA) has approved the Phase 1/2a clinical trial of its first-in-class anti-PAUF monoclonal antibody, PBP1510 (INN: Ulenistamab), for the treatment of pancreatic cancer. 

The clinical trial will be conducted on patients with advanced/metastatic pancreatic cancer in the Massachusetts General Hospital and the Ronald Reagan UCLA Medical Center by Principal Investigators (PI) comprised of leading authorities at Harvard Medical School and UCLA School of Medicine. The study aims to identify an optimal dose of PBP1510 in combination with gemcitabine through Phase 1 study and continue on Phase 2a to investigate clinical efficacy.

Pancreatic cancer is a highly aggressive malignancy which contributes to high morbidity and mortality with an overall survival rate in the U.S. of around 11%^¹)  at five years. Currently, the only curative options are surgical resection in combination with adjuvant chemotherapy. However, only 10 to 15%^²) of patients are candidates as the diagnosis occurs in advanced or metastatic stages that are surgically inoperable. Limited efficacy of treatment modalities and rapid progression of pancreatic cancer can be partly explained by Pancreatic Adenocarcinoma Up-regulated Factor (PAUF) found in majority of pancreatic cancer patients. PAUF plays an important role in disease progression, but no targeted molecular therapy against PAUF currently exists. Prestige BioPharma’s anti-PAUF antibody PBP1510 is envisioned to provide significant benefit to all patients affected by PAUF-positive pancreatic cancer.

The U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA) and Korean MFDS granted Orphan Drug Designation (ODD) to PBP1510 in 2020. ODD is granted to investigational drugs intended for the safe and effective treatment of rare diseases with an unmet medical need that affect few individuals but cause great suffering. This designation provides certain benefits and incentives including clinical protocol assistance, differentiated evaluation procedures for health technology assessments in certain countries, and if approved, marketing exclusivity in the EU for 10 years, in the U.S. for 7 years. 

http://mrem.bernama.com/viewsm.php?idm=43515

OurCrowd First Israeli Company to Partner With the Singapore Economic Development Board in the Global Innovation Alliance (GIA) Programme

 
Collaboration will further strengthen ties between startups and corporates in Israel and Singapore

JERUSALEM & SINGAPORE, June 29 (BUSINESS WIRE) -- OurCrowd, Israel’s most active venture firm, today announced its partnership with the Singapore Economic Development Board (EDB), under its Global Innovation Alliance (GIA) programme. The GIA is a platform that serves to catalyze cross-border collaboration between Singapore and major innovation hubs globally.

Israel joins the ranks of other notable tech hubs in the programme including Silicon Valley, China, and Europe. As the first Israeli company to run the programme, OurCrowd’s collaboration with EDB will provide thousands of Israeli startups the opportunity to work with Singapore-based corporates across the manufacturing and services sectors including healthcare, precision engineering and chemicals.

This collaboration includes a series of in-person meeetings and virtual programmes including curated networking sessions and bespoke demo days. The first such programme involving in-person meetings will be held in Israel this July, where invited Singapore-based corporates will meet with Israeli entrepreneurs to discuss collaboration opportunities in technology and innovation.

Yakir Machluf, OurCrowd’s newly appointed Head of Business Development said, “The partnership with EDB is the direct evolution of OurCrowd’s long standing relationships in Singapore and the entire region. Following the opening of the OurCrowd office in Singapore in 2016, as well as past collaborations with United Overseas Bank (UOB), Changi Airport, and Kepple, we will continue to strengthen the strategic partnerships driving corporate innovation between Singapore, the Israeli ecosystem and beyond.”

Ms Lily Phua, Vice President, Innovation Economy, EDB said, “With the reopening of global travel borders, our companies can now resume travel to meet with international partners to discuss growth opportunities and strengthen innovation collaborations. EDB is pleased to partner with OurCrowd to organise this series of programmes in Israel, which seek to enhance our companies’ capacity to create new products and businesses out of Singapore. Companies will be able to leverage OurCrowd’s extensive networks and deep understanding of technology capabilities in the Israeli startup ecosystem, which will further strengthen innovation ties between the two countries.”

Israeli startups that are interested to attend the GIA Israel programme in July 2022, please email Haley.silverstein@ourcrowd.com.

About OurCrowd:

OurCrowd is the online global venture investing platform that empowers institutions and individual accredited investors to invest and engage in emerging technology companies at an early stage. Acclaimed by PitchBook as the most active venture investor in Israel, OurCrowd vets and selects companies across all sectors and stages, invests its own capital, and provides its global platform of over 215,000 registered members from 195 countries with unparalleled access and freedom to co-invest from as little as $10,000 in the companies and funds of their choice.

Founded by CEO Jon Medved in 2013 with the vision of democratizing world-class venture capital investing, OurCrowd has grown rapidly into the world’s leading online venture investing platform and as of 2021 has received over $1.9 billion in commitments, and deployed capital into more than 347 portfolio companies and 39 funds across five continents. To date, OurCrowd’s startups have recorded 59 exits including several stock market listings: Beyond Meat, Lemonade, Innoviz, Hub Security; and numerous high-profile acquisitions: JUMP by Uber, BriefCam by Canon, Argus by Continental, Crosswise by Oracle, Replay by Intel, Corephotonics by Samsung, CyberX by Microsoft, and Kenna Security by Cisco. OurCrowd builds value for its portfolio companies throughout their lifecycles, providing mentorship, recruiting industry advisors, navigating follow-on rounds and creating growth opportunities through its network of multinational partnerships.

View source version on businesswire.com: 
https://www.businesswire.com/news/home/20220627005314/en/

Contact

PRESS CONTACT: Leah Stern, Partner, Global Communications @OurCrowd / Europe: +44 747 019 6826 / E: leah@ourcrowd.com

Source : OurCrowd

RESUMPTION OF PRODUCTION AT SHANGHAI FACTORIES

 SINGAPORE, June 28 (Bernama-GLOBE NEWSWIRE) -- The Board of Directors of CDW Holding Limited (the “Company”, and together with its subsidiaries, the “Group”) wishes to update shareholders on the status of production at the Group’s factories in Shanghai. The Group’s two factories located in Shanghai under its two wholly-owned subsidiaries, Crystal Display Components (Shanghai) Co., Limited (“SHCD”) and Tomoike Precision Machinery (Shanghai) Co., Limited (“SHTP”) had experienced temporary stoppages due to the Shanghai Municipal Government’s COVID-19 lockdown (the “Shanghai Lockdown”), which commenced on 1 April 2022.

As previously announced, the SHCD factory officially resumed its partial production on 9 May 2022 under a ‘closed loop’ manufacturing arrangement. Following the announcement to end COVID-19 lockdown by the Shanghai Municipal Government on 1 June 2022, both SHCD and SHTP factories have officially resumed production.

In Jiading district, where both SHCD and SHTP are located, there has been a normalisation of factory operations with no movement restrictions within the district. However, outward deliveries of goods to other provinces (“Outward Logistics”) are still subject to each destination’s local requirements, e.g. for drivers to provide 48 hours negative PCR test results and to remain in the vehicle cabin while goods are unloaded. Alternatively, Outward Logistics can be outsourced to logistics companies to handle. The delivery of raw materials to a factory (“Inward Logistics”) from suppliers or the port has returned to normal, with a permit being required.

The Group’s key customer has taken the initiative to have the backlog of orders in April and May for digital instrument panels for the automotive industry to be completed by September, on top of normal existing orders, including increasing production capacity. On the other hand, a major portion of the Office Automation business undertaken by SHTP has not received any instructions to date from customers to fulfill its April and May backlog orders, so these orders, might not be recovered. All customer visits to the two factories have been stopped for the time being, as these visits are still subject to quarantine.     

The production stoppages at the Group’s factories are likely to have an impact on the Group’s performance for the financial year ending 31 December 2022 (“FY2022”) and the Group will update shareholders once the financial impact of the production stoppages can be determined, if any. The Group’s other factories in China, located in Dongguan and Wuxi, have not had any production stoppages to date.

Shareholders of the Company and potential investors are advised to exercise caution when dealing in the shares of the Company. If in doubt as to the action they should take, shareholders and investors should consult their stockbrokers, bankers, solicitors, accountants, tax advisers or other professional advisers.

By Order of the Board
YOSHIKAWA Makoto
Chairman and Chief Executive Officer 


Issued on behalf of : CDW Holding Limited
Contact : Ivan Hong / Gerald Woon
Office : (65) 6704 9288
Email / DID / Mobile : ivanhong@cogentcomms.com / (65) 6704 9287 / (65) 9055 8883
woon@cogentcomms.com / (65) 6704 9268 / (65) 9694 8364 

SOURCE : CDW Holding Limited

Safe Security develops research model predicting industry's breach probability in 12 months

KUALA LUMPUR, June 28 (Bernama) -- Safe Security, a global leader in cybersecurity risk quantification and management, has released new findings to empower CISOs, risk teams, C-Suites, and board members to design and implement an ROI-driven enterprise cyber risk management plan.

In order to truly manage cyber risk, organisations should answer two questions: What is the probability of an attack happening? and, If an attack happens, what is the potential financial loss for the company?

To help organisations answer those questions based on industry data, Safe Security developed a research model that can predict the probability of a breach for any industry over the next 12 months.

Among others, the probability of a healthcare company falling victim to a successful cyber attack is 25 per cent and 20 per cent for a financial services company; industries like manufacturing and retail face less than 15 per cent probability of a successful cyber attack; and, in a ransomware attack, the cost of the ransom itself makes up only 10 per cent of the total financial impact the attack would have against an organisation.

Leveraging this research, Safe Security developed their CRQ Calculator, a free benchmarking tool providing outputs about the cyber health and potential financial risks of a specific industry. These outputs can be tuned specifically to a company based on its internal signals.

“As humans, we love predicting the future. Everything from which team will win tomorrow’s game, to the probability of rain next week.

“The Safe Security team feels just as passionate about helping organisations understand their cybersecurity risk through probability models,” said Saket Modi, co-founder and CEO of Safe Security in a statement.

“Like financial risk, cyber risk needs to be managed in real-time based on data coming from internal and external environments. CISOs can use the Safe CRQ Calculator to gain a quantified baseline to draft their cyber risk management plan over the next 12 months.”

For more information, visit https://www.safe.security/.

-- BERNAMA

MonetaGo Appoints Ben Arber US, Canada Managing Director

MonetaGo hires Ben Arber to derisk trade finance in the US and Canada (Photo: Business Wire)

KUALA LUMPUR, June 28 (Bernama) -- Financial technology solutions provider MonetaGo has appointed Ben Arber to the newly created role of managing director, US and Canada, effective immediately.

Based in New York, Arber will lead MonetaGo’s US and Canadian operations, bringing together North American and global financial institutions to drive adoption of the company’s universal, standardised deduplication utility, which combats financial fraud in trade finance.

Arber brings with him a wealth of trade finance, payments and commercial banking experience in North America, Asia and the Middle East.

His experience includes 24 years at HSBC in various international roles, including as head of their Canada global trade and receivables finance business which tripled in size under his leadership, and most recently as head of financial crime compliance for US commercial banking and global trade and receivables finance.

“Over the course of my career, I’ve engaged with regulators, policymakers and industry leaders on the opportunities and challenges in managing fraud and crime risk and seen first-hand how use of technology can make a difference,” says Arber in a statement.

“MonetaGo has developed a unique global solution to a pervasive problem, and I’m excited about driving its implementation in the US and Canadian markets. If we can stamp out the bad actors, we have the chance to make trade finance work better for everyone, and I’m looking forward to getting started.”

MonetaGo CEO and co-founder Jesse Chenard adds: “The current economic and geopolitical volatility is placing a squeeze on businesses. As they compete around the world, they need the right support to win global sales.

“Proven in production in its fifth year, MonetaGo’s Secure Financing system has already helped to unlock trade finance for companies both large and small. We’re thrilled to have a banking compliance veteran like Ben on board and look forward to tapping on his expertise in transforming, growing and de-risking the North American trade finance market.”

-- BERNAMA

HITACHI ENERGY AND PETROFAC TO COLLABORATE IN GROWING OFFSHORE WIND MARKET

 

Collaboration combines complementary technologies and expertise of both companies to increase customer value and help accelerate the energy transition


Zurich, Switzerland, June 28 (Bernama-GLOBE NEWSWIRE) -- Hitachi Energy a market and technology leader in transmission, distribution and grid automation solutions, and Petrofac, a leading international service provider to the energy industry, have entered into a collaboration to provide grid integration and associated infrastructure to support the rapidly growing offshore wind market.

This collaboration builds on the complementary core technologies and expertise of both companies in offshore wind to support the decarbonization of power systems and deliver clean energy. It covers high-voltage direct current (HVDC), as well as high-voltage alternating current (HVAC) solutions.

Hitachi Energy’s HVDC Light^® and modular HVAC grid technologies and solutions and Petrofac’s world-class engineering, procurement, construction and installation capabilities for offshore platforms and offshore and onshore civil works, will bring considerable benefits to the efficient implementation of offshore wind projects and help accelerate the energy transition.

“We are delighted to collaborate with Petrofac to help meet the growing need for large-scale offshore wind generation and deliver clean renewable electricity to consumers. As leaders in our respective fields, this collaboration will create added value for our customers and help accelerate the energy transition,” said Niklas Persson, Managing Director of Hitachi Energy’s Grid Integration business. “Our HVDC and HVAC solutions are key enablers of the transition to a global energy system that is more sustainable, flexible and secure.”

“Offshore wind plays a crucial role in the transition to clean, affordable energy and we’ve been successfully delivering major projects in the sector for more than a decade now,” said Elie Lahoud, Chief Operating Officer, Engineering & Construction of Petrofac. “Hitachi Energy is well known for its long track record in providing innovative technologies and solutions across the power grid value chain. We look forward to bringing our industry-leading experience and deep domain knowledge together, to benefit our customers and power millions more homes using renewable energy.”

Recent Hitachi Energy HVDC offshore wind projects include Dogger Bank, the world’s largest offshore wind farm off the UK coast, and four of the DolWin and BorWin HVDC hubs that connect multiple wind farms in the North Sea to the German power grid.

Hitachi Energy is also a global leading supplier of grid connection solutions for the AC offshore wind farms industry.

Editor’s notes

Offshore wind is undergoing unprecedented growth globally. In 2021, a record 15.7 gigawatts (GW) of capacity were added, compared to around 5.2 GW per year in 2020 and 2019, according to World Forum Offshore Wind.¹ 

Hitachi Energy pioneered HVDC almost 70 years ago and has delivered more than half of the world’s HVDC projects and more than 70 percent of the world’s voltage source converter (HVDC Light) installations. HVDC Light is the technology of choice for transferring power over long distances from offshore wind farms to the mainland grid. Its defining features include uniquely compact converter stations (which is extremely important in space-critical applications like offshore wind platforms), exceptionally low electrical losses of less than 1 percent, and black-start capability to restore power after a grid outage.

1. https://wfo-global.org/wp-content/uploads/2022/02/WFO_Global-Offshore-Wind-Report-2021.pdf

- End -

About Hitachi Energy Ltd.

Hitachi Energy is a global technology leader that is advancing a sustainable energy future for all. We serve customers in the utility, industry and infrastructure sectors with innovative solutions and services across the value chain. Together with customers and partners, we pioneer technologies and enable the digital transformation required to accelerate the energy transition towards a carbon-neutral future. We are advancing the world’s energy system to become more sustainable, flexible and secure whilst balancing social, environmental and economic value. Hitachi Energy has a proven track record and unparalleled installed base in more than 140 countries. Headquartered in Switzerland, we employ around 38,000 people in 90 countries and generate business volumes of approximately $10 billion USD.

https://www.hitachienergy.com

https://www.linkedin.com/company/hitachienergy

https://twitter.com/HitachiEnergy

About Hitachi, Ltd.

Hitachi drives Social Innovation Business, creating a sustainable society with data and technology. We will solve customers' and society's challenges with Lumada solutions leveraging IT, OT (Operational Technology) and products, under the business structure of Digital Systems & Services, Green Energy & Mobility, Connective Industries and Automotive Systems. Driven by green, digital, and innovation, we aim for growth through collaboration with our customers. The company’s consolidated revenues for fiscal year 2021 (ended March 31, 2022) totaled 10,264.6 billion yen ($84,136 million USD), with 853 consolidated subsidiaries and approximately 370,000 employees worldwide. For more information on Hitachi, please visit the company's website at https://www.hitachi.com.


Jocelyn Chang
Hitachi Energy Ltd.
jocelyn.chang@hitachienergy.com

SOURCE : Hitachi Energy Ltd.

NIELSENIQ ACCELERATES EXPANSION OF GLOBAL RETAIL STRATEGY WITH ADDITION OF RETAIL LAB LEADER, DAWN E. NORVELL

 CHICAGO, June 28 (Bernama-BUSINESS WIRE) -- NielsenIQ has strengthened its leading global retail practice with the addition of Dawn E. Norvell as Global Head of the newly formed NielsenIQ Retail Lab. In her new role, Norvell will lead a progressive team created to better identify retail client needs, design solutions, and enable retailers to use NielsenIQ's full suite of products to help drive their business. Norvell will build a sales and commercial management strategy designed to expand NielsenIQ's retail analytics focus and enable growth within the business unit.

“The NielsenIQ Retail Lab is an important part of our global retail strategy & company success, and Dawn’s industry-leading knowledge and background in the global marketplace gives a rare viewpoint of the current retail climate,” said David Johnson, Global President of Retail at NielsenIQ. “Her extensive first-hand experience will enhance our broad range of go-to-market client offerings and add significant depth to our retail team. We are thrilled that NielsenIQ continues to attract the highest talent of innovative thinkers and visionary leaders.”

Norvell is a visionary business leader with a proven track record of success and extensive retail experience. Her expertise in consumer and manufacturer data analytics, bridging complex solutions to solve business problems and in profit and loss management and consumer-led business strategy will enable us to deliver strong, long-term business results.

“The move to NielsenIQ is an exciting one for me because the company's reputation for excellent client service and its dedication to delivering expert analysis of consumer and market trends Is unmatched,” Dawn E. Norvell said. “I was also drawn to the company's new Retail Lab, a true Innovative lab concept that allows the discovery of a retailer's root issues, the ability to address these issues, and the opportunity to monetize the retailer's strengths. I look forward to driving strong business results by leading and developing a diverse team of innovative thinkers and talented professionals in the NielsenIQ Retail Lab.”

Prior to joining NielsenIQ, Norvell spent more than 10 years at Walmart, where she served as both a senior merchant and a category marketer across food, consumables, and beauty. She has been recognized by various industry awards, including Walmart’s Merchandising Excellence Impact Award and Walmart’s Risk Thinking Award. In addition, Norvell has been featured as a key speaker in numerous industry events and was highlighted as a “Pretty Powerful” beauty industry executive in Essence Magazine’s “Black Women in Beauty: 15 Beauty Executives Who Are Changing the Industry.”

About NielsenIQ

NielsenIQ, a global information services company, delivers the gold standard in consumer and retail measurement, through the most connected, complete, and actionable understanding of the evolving global, omnichannel consumer. NielsenIQ is the source of confidence for the industries we serve and the pioneer defining the next century of consumer and retail measurement. Our data, connected insights, and predictive analytics optimize the performance of CPG and retail companies, bringing them closer to the communities they serve and helping to power their growth.

NielsenIQ, an Advent International portfolio company, has operations in 90+ markets, covering more than 90% of the world’s population. For more information, visit NielsenIQ.com.

View source version on businesswire.com: 
https://www.businesswire.com/news/home/20220627005238/en/

Contact

Gillian Mosher
VP, Communication
Gillian.mosher@nielseniq.com

Source : NielsenIQ